Position in NVS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$56,732
New position
Shares Held
362
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1,421
of 1,603 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 26%
Shared 0%
None 74%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026First Bancorp, Inc /ME/ holds $5,656,881 across 11 Drug Manufacturers - General names. NVS ranks #10 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
8,272 | $2,100,838 | |
| 2 | ABBV |
AbbVie Inc.
|
3,278 | $824,875 | |
| 3 | MRK |
Merck & Co., Inc.
|
5,509 | $707,906 | |
| 4 | PFE |
Pfizer Inc
|
20,600 | $496,047 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
7,257 | $418,147 | |
| 6 | LLY |
ELI LILLY & Co
|
290 | $347,834 | |
| 7 | AMGN |
Amgen Inc
|
720 | $260,726 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,700 | $214,778 |
All Filings in NVS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $56,732 | 362 | Shares | Sole | 2026-08-11 | |
| No filing history on record for this holder in this stock. | ||||||